secwatch.observer — SEC 8-K summary
======================================

Issuer:     Pasithea Therapeutics Corp. (KTTA)
CIK:        0001841330
Form:       8-K
Filed at:   2025-12-15T23:59:59+00:00
Accession:  0001213900-25-121466
Event type: regulatory
Sentiment:  positive
Materiality: 0.45
Item codes: 8.01
LLM model:  deepseek-v4-flash:cloud@v2

Pasithea Therapeutics regains Nasdaq minimum bid price compliance
-----------------------------------------------------------------

- Received Nasdaq deficiency notice on June 23, 2025 for failing $1.00 minimum bid price rule 5550(a)(2).
- Compliance deadline was December 22, 2025; on December 12, 2025 Nasdaq confirmed compliance.
- Common stock (KTTA) maintained closing bid at or above $1.00 for sufficient consecutive business days.
- Nasdaq notified company that the bid price deficiency matter is now closed.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1841330/000121390025121466/0001213900-25-121466-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1841330/000121390025121466/ea0269602-8k_pasithea.htm
  HTML page:      https://secwatch.observer/filing/0001213900-25-121466

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer